An international perspective on pediatric psychopharmacology

Benedetto Vitiello

Research output: Contribution to journalArticle

Abstract

The use of pharmacotherapy for children and adolescents with mental disorders varies widely across countries. More than 80% of the world use of stimulant medications occurs in the USA. The use of antidepressants and antipsychotics is many times greater in the USA than in other countries. Factors likely to influence the pediatric use of psychotropic medications are here examined and discussed. Variability in use reflects differences in diagnostic systems, clinical practice guidelines, drug regulation, health services organization, availability and allocation of financial resources, and cultural attitudes towards childhood behavioral and emotional disturbances. Cultural context seems to exert a greater influence on the identification and management of psychiatric disorders than on other areas of medicine. It is currently unknown if the heterogeneity in treatment approaches results in differential clinical outcomes and prognosis. A better understanding of the factors underlying international variability may help clarify the process of diagnosis and treatment selection in child and adolescent psychiatry.

Original languageEnglish (US)
Pages (from-to)121-126
Number of pages6
JournalInternational Review of Psychiatry
Volume20
Issue number2
DOIs
StatePublished - Apr 2008
Externally publishedYes

Fingerprint

Psychopharmacology
Internationality
Pediatrics
Adolescent Psychiatry
Child Psychiatry
Health Services Accessibility
Affective Symptoms
Resource Allocation
Drug and Narcotic Control
Practice Guidelines
Mental Disorders
Antidepressive Agents
Antipsychotic Agents
Psychiatry
Medicine
Organizations
Drug Therapy
Therapeutics

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

An international perspective on pediatric psychopharmacology. / Vitiello, Benedetto.

In: International Review of Psychiatry, Vol. 20, No. 2, 04.2008, p. 121-126.

Research output: Contribution to journalArticle

Vitiello, Benedetto. / An international perspective on pediatric psychopharmacology. In: International Review of Psychiatry. 2008 ; Vol. 20, No. 2. pp. 121-126.
@article{7f00e9e53fc647cd8c11a32479df882d,
title = "An international perspective on pediatric psychopharmacology",
abstract = "The use of pharmacotherapy for children and adolescents with mental disorders varies widely across countries. More than 80{\%} of the world use of stimulant medications occurs in the USA. The use of antidepressants and antipsychotics is many times greater in the USA than in other countries. Factors likely to influence the pediatric use of psychotropic medications are here examined and discussed. Variability in use reflects differences in diagnostic systems, clinical practice guidelines, drug regulation, health services organization, availability and allocation of financial resources, and cultural attitudes towards childhood behavioral and emotional disturbances. Cultural context seems to exert a greater influence on the identification and management of psychiatric disorders than on other areas of medicine. It is currently unknown if the heterogeneity in treatment approaches results in differential clinical outcomes and prognosis. A better understanding of the factors underlying international variability may help clarify the process of diagnosis and treatment selection in child and adolescent psychiatry.",
author = "Benedetto Vitiello",
year = "2008",
month = "4",
doi = "10.1080/09540260801887710",
language = "English (US)",
volume = "20",
pages = "121--126",
journal = "International Review of Psychiatry",
issn = "0954-0261",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - An international perspective on pediatric psychopharmacology

AU - Vitiello, Benedetto

PY - 2008/4

Y1 - 2008/4

N2 - The use of pharmacotherapy for children and adolescents with mental disorders varies widely across countries. More than 80% of the world use of stimulant medications occurs in the USA. The use of antidepressants and antipsychotics is many times greater in the USA than in other countries. Factors likely to influence the pediatric use of psychotropic medications are here examined and discussed. Variability in use reflects differences in diagnostic systems, clinical practice guidelines, drug regulation, health services organization, availability and allocation of financial resources, and cultural attitudes towards childhood behavioral and emotional disturbances. Cultural context seems to exert a greater influence on the identification and management of psychiatric disorders than on other areas of medicine. It is currently unknown if the heterogeneity in treatment approaches results in differential clinical outcomes and prognosis. A better understanding of the factors underlying international variability may help clarify the process of diagnosis and treatment selection in child and adolescent psychiatry.

AB - The use of pharmacotherapy for children and adolescents with mental disorders varies widely across countries. More than 80% of the world use of stimulant medications occurs in the USA. The use of antidepressants and antipsychotics is many times greater in the USA than in other countries. Factors likely to influence the pediatric use of psychotropic medications are here examined and discussed. Variability in use reflects differences in diagnostic systems, clinical practice guidelines, drug regulation, health services organization, availability and allocation of financial resources, and cultural attitudes towards childhood behavioral and emotional disturbances. Cultural context seems to exert a greater influence on the identification and management of psychiatric disorders than on other areas of medicine. It is currently unknown if the heterogeneity in treatment approaches results in differential clinical outcomes and prognosis. A better understanding of the factors underlying international variability may help clarify the process of diagnosis and treatment selection in child and adolescent psychiatry.

UR - http://www.scopus.com/inward/record.url?scp=41749094975&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41749094975&partnerID=8YFLogxK

U2 - 10.1080/09540260801887710

DO - 10.1080/09540260801887710

M3 - Article

VL - 20

SP - 121

EP - 126

JO - International Review of Psychiatry

JF - International Review of Psychiatry

SN - 0954-0261

IS - 2

ER -